Optic
PrivateLast Round
Seed
Jul 20, 2022
Total Funding Raised
$11M
Company Overview
Optic operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in July 2022.
Optic is a biotechnology company that provides an AI-powered platform for drug discovery, asset identification, and strategic intelligence for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Business Intelligence
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optic Comparables
Compare Optic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convexia | 79% | |
| Perceptic | 76% | |
| Xaira Therapeutics | 75% |
For institutional investors. Book with your work email.
Optic Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Optic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Greylock Partners | Seed |
| Neon DAO | Seed |
| Kleiner Perkins | Seed |
| Pantera Capital | Seed |
| Lattice Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 61% MoM, reaching 9.4K.
- Feb 23, 2026
Published paper on AI-driven drug asset scouting with Luba Greenwood.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueAug 10, 2026
Optic Inc. records estimated revenue of $19.9M in Sep '25.
For institutional investors. Book with your work email.
Optic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Optic's valuation, stock price, and market status.
Is Optic a public or private company?
Optic is a private company.
What is the current stock price of Optic?
Optic is a private company, so its shares have no public market price. Caplight tracks Optic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Optic worth (valuation)?
Valuation information for Optic is not publicly available.
Can I buy Optic stock?
Optic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Optic's last funding round?
Optic's most recent funding round was Seed on July 20, 2022.
Who are the main investors in Optic?
Key investors in Optic include Kleiner Perkins, Pantera Capital.
Will Optic IPO soon?
No public IPO plans have been announced for Optic.
How can I track Optic secondary market activity?
Caplight tracks bids, offers, and trades in Optic's shares on secondary markets.